Scarica l'app Stockscreener
20.64
0.83%
0.17
Dopo l'orario di chiusura:
20.68
0.04
+0.19%
Precedente Chiudi:
$20.47
Aprire:
$20.66
Volume 24 ore:
6.83M
Relative Volume:
0.98
Capitalizzazione di mercato:
$10.25B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
51.60
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+5.25%
1M Prestazione:
+18.96%
6M Prestazione:
+112.35%
1 anno Prestazione:
+42.34%
Intervallo 1D:
$20.39
$20.89
Intervallo di 1 settimana:
$19.42
$20.92
Portata 52W:
$8.02
$20.92
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
20.64 | 10.17B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
146.42 | 64.92B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.60 | 45.60B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
8.95 | 39.54B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.01 | 23.00B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
453.07 | 20.06B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Can Elanco Animal Health Incorporated rally from current levelsQuarterly Market Summary & AI Enhanced Execution Alerts - newser.com
Using economic indicators to assess Elanco Animal Health Incorporated potentialJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - newser.com
Visual analytics tools that track Elanco Animal Health Incorporated performance2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
What catalysts could drive Elanco Animal Health Incorporated stock higherGold Moves & Safe Entry Zone Tips - newser.com
Elanco Animal Health Hits New 52-Week High of $20.91 - Markets Mojo
Elanco Animal Health (ELAN) Is Up 8.2% After FDA Strengthens Zenrelia Safety Labeling – Has the Bull Case Changed? - simplywall.st
Q&A with Elanco’s Jeff Simmons on blockbusters, challenges and growing up on a vineyard - Indianapolis Business Journal
After 5 years, Elanco moves in to west side Indy headquarters. Take a look inside - IndyStar
Is this a good reentry point in Elanco Animal Health IncorporatedInsider Buying & AI Based Buy/Sell Signal Reports - newser.com
Can Elanco Animal Health Incorporated stock attract ESG investmentsTrade Risk Assessment & Accurate Technical Buy Alerts - newser.com
Is Elanco Animal Health Incorporated stock a smart buy before Fed meetingTrade Risk Summary & Community Trade Idea Sharing - newser.com
How to build a dashboard for Elanco Animal Health Incorporated stockPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Sentiment analysis tools applied to Elanco Animal Health Incorporated2025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
ASR Vermogensbeheer N.V. Trims Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE:ELAN) Reaches New 1-Year HighHere's What Happened - MarketBeat
Elanco Opens New $200 Million Global Headquarters in Downtown Indianapolis - Hoosier Ag Today
IEDC approves $10M in federal funding to launch Indianapolis venture studio - Inside INdiana Business
Elanco opens new headquarters, some anticipate era of health innovation in the state - WFYI
Elanco Animal Health Hits New 52-Week High at $20.19 - Markets Mojo
Ribbon cut on $200 million Elanco animal health campus - Fox 59
Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement - GuruFocus
Elanco Animal Health (ELAN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Why Elanco Animal Health Incorporated stock fits value portfolios2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
Elanco Animal Health Hits New 52-Week High at $19.70 - Markets Mojo
Why retail investors pile into Elanco Animal Health Incorporated stock2025 Stock Rankings & Daily Chart Pattern Signals - newser.com
Elanco Animal Health (ELAN): Valuation in Focus Following FDA-Backed Zenrelia Label Upgrade - simplywall.st
Elanco Animal Health Hits New 52-Week High at $19.27 - Markets Mojo
Elanco Animal Health stock reaches 52-week high at 19.36 USD - Investing.com Canada
Assessing Elanco Animal Health: Insights From 6 Financial Analysts - Benzinga
Elanco Animal Health (ELAN) Receives Price Target Boost from Sti - GuruFocus
Stifel Nicolaus Raises Elanco Animal Health (NYSE:ELAN) Price Target to $23.00 - MarketBeat
Why Elanco (ELAN) Stock Is Up Today - TradingView
BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Raises Target Price to $23 - 富途牛牛
Stifel raises Elanco Animal Health stock price target to $23 on strong product growth - Investing.com
Elanco Animal Health Hits New 52-Week High at $19.34 - Markets Mojo
Elanco Animal Health Incorporated (ELAN) Joins S&P MidCap 400 Following Strong Q2 Growth and Product Ramp-Up - Yahoo Finance
Elanco (ELAN) Advances with FDA Label Update for Zenrelia - GuruFocus
Elanco (ELAN) Updates Zenrelia Label Following FDA Review - GuruFocus
FDA Removes Key Safety Warning: Elanco's Zenrelia Pet Drug Shows Strong Safety Profile After 500K+ Dogs Treated - Stock Titan
Elanco Animal Health Incorporated's (NYSE:ELAN) Stock Is Going Strong: Have Financials A Role To Play? - 富途牛牛
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
9.21%
0.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):